Prefilled Syringes Market to Expand at 13.3% CAGR – 2019 driven by Growing Demand for Glass Prefilled Syringes
In the injectable drug delivery devices market, the prefilled syringes segment is one of the fastest growing segments. Various benefits of prefilled syringes including reduced risk of cross contamination, and ease of handling and administration have led to their increased demand in the market.
The report states that the continuous growth in the injectable drugs market worldwide has boosted the growth of the global prefilled syringes market. The advantages of prefilled syringes over conventional vials and syringe packing systems have supported the market’s growth. Increase in the demand for point-of-care administration and technological advancements in the manufacturing of prefilled syringes are expected to augment the growth of the market during the forecast horizon. However, the introduction of alternative drug delivery methods might hamper the growth of the market.
Download free exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3952
Transparency Market Research has recently published a report on the global prefilled syringes market. The report, titled “Prefilled Syringes Market – Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 – 2019,” offers an insightful study on the global prefilled syringes market and projects the expansion of the market at a CAGR of 13.3% during the period from 2013 to 2019. The global prefilled syringes market stood at a valuation of US$2.09 bn in 2012 and is anticipated to be worth US$4.98 bn by 2019. The report identifies the key factors impacting the growth of the market and profiles some of the prominent players in the market.
Some of the key players in the global prefilled syringes market are Schott AG, Gerresheimer AG, Becton, Dickinson and Company, Nipro Corporation, Baxter International Inc., Ypsomed Holding AG, Stevanato Group, Unilife Corporation, Bespak, West Pharmaceutical Services, Inc., and Vetter Pharma International GmbH. These players have been profiled on the basis of company overview, product portfolio, and financial overview. For the new and existing players in the market, the report offers strategic recommendations such as the adoption of polymer technology for the manufacturing of prefilled syringes and investments in the emerging markets in North America.